FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly

The Wall Street JournalView source article

Part of story

FDA clears Roche and Eli Lilly's blood test for Alzheimer's disease detection

The FDA has cleared a blood test developed by Roche and Eli Lilly to help identify signs of Alzheimer's disease in people aged 55 and older with cognitive decline.

Aug 24, 20263 sourcesBiomarkers & bloodwork testing Alzheimer’s & dementia Preventive medicine Eli Lilly

FDA clears Roche and Eli Lilly's blood test for Alzheimer's disease detection

Other sources for this story

The Washington Post

FDA approves a new blood test to detect signs of Alzheimer’s

Reuters

Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance | Reuters

Featured Stories

CIA Director John Ratcliffe arrives in Moscow aboard US military plane for meetings

Aug 25, 20268 sources